CSNK1A1, KDM2A, and LTB4R2 Are New Druggable Vulnerabilities in Lung Cancer.
Sauta E, Reggiani F, Torricelli F, Zanetti E, Tagliavini E, Santandrea G, Gobbi G, Strocchi S, Paci M, Damia G, Bellazzi R, Ambrosetti D, Ciarrocchi A, Sancisi V.
Sauta E, et al. Among authors: reggiani f.
Cancers (Basel). 2021 Jul 12;13(14):3477. doi: 10.3390/cancers13143477.
Cancers (Basel). 2021.
PMID: 34298691
Free PMC article.